HealthCareEquipment.org


Status: In Stock

CONTAK RENEWAL CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR


A Cardiac Resynchronization Therapy Defibrillator Related Image

(Not Necessarily related to the device)

Description:

CONTAK RENEWAL CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR by Boston Scientific Corp.

Boston Scientific Corp. presents the CONTAK RENEWAL CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR, an advanced medical device designed to promote optimal heart function in patients with heart disease. This device is mainly used for patients suffering from heart failure and arrhythmias.

The CONTAK RENEWAL CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR is a multi-faceted, implantable device that offers three primary benefits: managing patient's heart rhythm, providing cardiac resynchronization therapy (CRT), and defibrillation therapy. It is a critical tool in the detection and correction of life-threatening ventricular arrhythmias.

1. Heart Rhythm Management: The device continuously monitors the patient's heart rate, detecting and addressing any incidences of abnormal rhythms, effectively preventing cardiac episodes before they occur.

2. Cardiac Resynchronization Therapy (CRT): For patients with heart failure due to dyssynchrony, where the heart’s chambers are not beating together, the device synchronizes the beating of the heart's chambers, subsequently improving the heart's efficiency and the patient's overall quality of life.

3. Defibrillation Therapy: In case of very fast, potentially fatal heart rhythms (arrhythmias), the device delivers a high energy shock to the heart muscle, essentially 'resetting' the heart to its normal rhythm.

The CONTAK RENEWAL CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR by Boston Scientific Corp. is a pivotal tool in maintaining heart health and improving patient outcomes for sufferers of heart disease.


Primary Use:

CONTAK RENEWAL CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR


Primary Medical Use
The CONTAK RENEWAL CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR, primarily, is a sophisticated device used to correct ventricle dysfunctions in the heart. It performs dual functionality/roles of a Cardiac Resynchronization Therapy (CRT) device and an Implantable Cardioverter-Defibrillator (ICD).

Cardiac Resynchronization Therapy (CRT):
As a CRT device, it performs the crucial role of alleviating dysfunctions related to heart rhythm. In patients suffering from heart failure, the heart's ventricles often fail to contract in a synchronized and efficient manner. The CRT feature of this device combats this issue by transmitting tiny electrical impulses t


How It Works:

CONTAK RENEWAL CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR Explained

The CONTAK RENEWAL Cardiac Resynchronization Therapy Defibrillator is an advanced, implantable medical device designed to alleviate heart failure symptoms and prevent sudden cardiac death. This device combines the functionalities of a standard Implantable Cardioverter Defibrillator (ICD) and a Cardiac Resynchronization Therapy (CRT) pacemaker into one integral unit.

Operating Principles

This innovative device operates on the principle of biventricular pacing. It comprises two leads placed in the right atrium and the right ventricle, and an additional lead placed in the coronary sinus to pace the left ventricle. The simultaneous pacing of both ventricles—also referred to as cardiac resynchronization, enhances the synchronization of the left and right chambers of the heart, leading to an improvement in cardiac function and patient quality of life. The ICD component of the device closely monitors heart rhythms. In the event of life-threatening arrhythmias such as Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT), a high-energy shock is delivered to restore normal rhythm.

Advantages

The integration of these two primary functionalities -- Cardiac Resynchronization and Defibrillation -- into a single device reduces the need for multiple procedures, enhancing overall patient care. Moreover, it maximizes treatment options for patients suffering from severe and moderate heart failure that remain symptomatic despite optimal medical therapy.

Key Features

1. Heart Rhythm Management: It relentlessly monitors the patient's heart rhythm, and when abnormalities are detected, it delivers small or high-energy shocks to restore the rhythm. 2. Cardiac Resynchronization: It ensures the heart's lower chambers, the ventricles, pump at the same time — improving the heart's overall blood pumping efficiency. 3. Data Storage: The CONTAK RENEWAL device archives up to fourteen minutes of electrocardiogram data, retaining crucial information about the patient's heart rhythm prior to, during, and after an arrhythmic episode. In conclusion, the CONTAK RENEWAL Cardiac Resynchronization Therapy Defibrillator is a well-rounded device that delivers comprehensive cardiovascular care. It fortifies the practitioners' armamentarium, offering a versatile treatment modality for patients presenting with heart failure and ventricular arrhythmias.

Manufacturer:

Boston Scientific Corp.


Status: In Stock


Are you the owner or manufacturer of this device? Need to update anything on this page or get in touch with us? Click here.

×

Owner/Manufacturer Registration

Thank you for your submission!

We will get in touch with you shortly.